Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest
NCT05756621
Cardiac Arrest, Cardiovascular Diseases
Brescia, BS, Italy
View Trial DetailsNCT Number: NCT00318578
The aim of the study is to evaluate, prospectively, prognosis factors associated with convulsive status epilepticus (CSE) in adults hospitalized in intensive care units.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Centre Hospitalier d'Abbeville, Abbeville, France
Status epilepticus is a neurologic and medical emergency associated with high mortality and morbidity rates. According to the operational definition Convulsive Status Epilepticus (CSE) is defined as a single clinical seizure lasting more than 10 min, or two or more repeated seizures over a period of more than 10 minutes without intervening recovery of consciousness.
There are a few to date in literature reporting prognosis factors associated with this condition and, at this time, there are no published data considering an operational definition of CSE.
In a retrospective study considering an operational definition we identified a seizure duration of 15 min associated with poor outcome (not yet published).
The principal goal of this study is to evaluate factors associated with outcome in CSE, in particular seizure duration of more than 15 minutes.
The secondary goals are to evaluate the epidemiology and management at every stage of CSE thus redefined.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Versailles Hospital
Other
Prognosis Factors Associated With Convulsive Status Epilepticus in Adults: A Multicenter Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05756621
Cardiac Arrest, Cardiovascular Diseases
Brescia, BS, Italy
View Trial DetailsNCT07689084
Brain Diseases, Central Nervous System Diseases
Marburg, Hesse, Germany
View Trial DetailsNCT07443241
Nervous System Diseases, Neurologic Manifestations
View Trial DetailsNCT07163572
Nervous System Diseases, Neurologic Manifestations
Multan, Punjab Province, Pakistan
View Trial Details